Company Profiles

driven by the PitchBook Platform

Abexxa Biologics

Description

Developer of antibody based therapeutics based on immunotherapy research.

2015

Founded

PRIVATE

Status

11-50

Employees

Seed

Latest Deal Type

$1.25M

Latest Deal Amount

$1.25M

Total Amount Raised

Description

Developer of antibody based therapeutics based on immunotherapy research.

Website:

www.abexxabio.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Other Healthcare

Primary Office

NanoFab Building, 500 South Cooper Street Suite 203 Arlington, TX 76019United States +1 (512) 497-5742
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Abexxa Biologics's full profile, request a free trial.

Abexxa Biologics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Abexxa Biologics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Abexxa Biologics Executive Team (2)

NameTitleBoard
Seat
Contact
Info
Debra WeidanzPresident and Director
Jon Weidanz Ph.DPresident & Director
Debra Weidanz President and Director
Jon Weidanz Ph.D President & Director

Abexxa Biologics Board Members (1)

NameRepresentingRoleSinceContact
Info
Martin HeideckerAbexxa BiologicsBoard Member000 0000
Martin Heidecker Board Member Abexxa Biologics
Request full access to PitchBook